ACMG policy statement: Updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing

Genetics in Medicine

Volumn 17, Issue 1, 2015, Pages 68-69

  Watson, Michael S ^a  

^a American College of Medical Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMERICAN COLLEGE OF MEDICAL GENETICS AND GENOMICS POLICY; BIOETHICS; COLLEGE; CONSENSUS; DECISION MAKING; EXOME; GENE; GENE SEQUENCE; GENETICS; GENOME; GENOME SCALE SEQUENCING; GENOMICS; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; MEDICAL GENETICS; MEDICINE; REVIEW; HIGH THROUGHPUT SEQUENCING; INCIDENTAL FINDING; ORGANIZATION; PRACTICE GUIDELINE; PROCEDURES;

GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INCIDENTAL FINDINGS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES;

EID: 84920528362     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2014.151     Document Type: Review

References (2)

1. Presidential Commission for the Study of Bioethical Issues. Anticipate and Communicate: Ethical Management of Incidental and Secondary Findings in the Clinical, Research, and Direct-to-Consumer Contexts. http://bioethics.gov/node/3183.
2. Scheuner MT, et al. Reporting genomic secondary findings: ACMG members weigh in Genet Med 2014;17:27-35.